1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012;100(Pt B):1-441.
3. Mostafa HM, Sheweita SA, O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999;12:97-111.
4. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001;7:558-561.
5. Heyns CF, van der Merwe A. Bladder cancer in Africa. Can J Urol 2008;15:3899-3908.
6. Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 2008;19:421-429.
7. Shiff C, Naples JM, Isharwal S, Bosompem KM, Veltri RW. Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? Trans R Soc Trop Med Hyg 2010;104:3-5.
10. Nweke CP, Shiff CJ, Okudo JC. The etiological association between Schistosoma hematobium infestation and bladder cancer in Africa and the Middle East. Peak J Public Health Manag 2015;3:10-17.
11. Kuntz RE, Cheever AW, Myers BJ, Young SW, Moore JA. Calcification of the bladder and papillary tumours of the bladder and ureters in gibbons (
Hylobates lar) infected with
Schistosoma haematobium (Iran). Trans R Soc Trop Med Hyg 1975;69:494-502.
12. Hicks RM, James C, Webbe G. Effect of
Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon. Br J Cancer 1980;42:730-755.
14. Henriques A, Arantes-Rodrigues R, I Faustino-Rocha A, I Teixeira-Guedes C, Pinho-Oliveira J, Talhada D, H Teixeira J, Andrade A, Colaço B, N Paiva-Cardoso M, J Pires M, Mvd Ferreira A, M Nunes F, A Oliveira P. The effects of whole green tea infusion on mouse urinary bladder chemical carcinogenesis. Iran J Basic Med Sci 2014;17:145-148.
15. Fu CL, Apelo CA, Torres B, Thai KH, Hsieh MH. Mouse bladder wall injection. J Vis Exp 2011;12:e2523.
16. Fu CL, Odegaard JI, Herbert DR, Hsieh MH. A novel mouse model of
Schistosoma haematobium egg-induced immunopathology. PLoS Pathog 2012;8:e1002605.
17. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and genetics of tumors of the urinary system and male genital organs. WHO, IARC Press. 2004.
18. Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, Wu XR, Kopelovich L, Rao CV.
p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia 2013;15:966-974.
19. Liang Z, Xie W, Wu R, Geng H, Zhao L, Xie C, Li X, Zhu M, Zhu W, Zhu J, Huang C, Ma X, Wu J, Geng S, Zhong C, Han H. Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin. Int J Clin Exp Pathol 2015;8:4503-4513.
20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
21. Espíndola MS, Frantz FG, Soares LS, Masson AP, Tefé-Silva C, Bitencourt CS, Oliveira SC, Rodrigues V, Ramos SG, Silva CL, Faccioli LH. Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during
Schistosoma mansoni infection. BMC Infect Dis 2014;14:263.
22. Ding W, Gou Y, Sun C, Xia G, Wang H, Chen Z, Tan J, Xu K, Qiang D.
Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and
Ki-67 expression could improve the risk stratification of NMIBC. Urol Oncol 2014;32:42. e13-19.
23. Hu HY, Liu H, Zhang JW, Hu K, Lin Y. Clinical significance of Smac and
Ki-67 expression in pancreatic cancer. Hepatogastroenterology 2012;59:2640-2643.
24. Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Mol Cancer Ther 2007;6:3248-3255.
27. Sobecki M, Mrouj K, Camasses A, Parisis N, Nicolas E, Llères D, Gerbe F, Prieto S, Krasinska L, David A, Eguren M, Birling MC, Urbach S, Hem S, Déjardin J, Malumbres M, Jay P, Dulic V, Lafontaine DLj, Feil R, Fisher D. The cell proliferation antigen
Ki-67 organizes heterochromatin. ELife 2016;5:e13722.
28. Lozano G. Mouse models of
p53 functions. Cold Spring Harb Perspect Biol 2010;2:a001115.
29. Yamamoto S, Chen T, Murai T, Mori S, Morimura K, Oohara T, Makino S, Tatematsu M, Wanibuchi H, Fukushima S. Genetic instability and
p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 1997;18:1877-1882.
30. Helal Tel A, Fadel MT, El-Sayed NK. Human papilloma virus and
p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factor. Pathol Oncol Res 2006;12:173-178.
31. Honeycutt J, Hammam O, Hsieh MH.
Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on
p53 are modulated by host sex. Exp Parasitol 2015;158:55-60.
33. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of
vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007;313:2050-2062.
34. Ding X, Wang Y, Ma X, Guo H, Yan X, Chi Q, Li J, Hou Y, Wang C. Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Cell Prolif 2014;47:146-151.
35. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.